Phase I Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer
Phase of Trial: Phase I
Latest Information Update: 24 May 2018
At a glance
- Drugs Fostamatinib (Primary) ; Paclitaxel (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 31 Jan 2018 Status changed from not yet recruiting to recruiting.
- 16 Oct 2017 Planned initiation date changed from 1 Oct 2017 to 1 Jan 2018.
- 16 Aug 2017 New trial record